The invention discloses a serum
metabolism marker combination for
ectopic pregnancy diagnosis and rupture risk prediction and application of the serum
metabolism marker combination, and relates to the technical field of biological science. The metabolic
fingerprint diagnosis model (AUCgt, 0.91) and the
metabolic marker panel (AUCgt, 0.92) have the advantages that the performance of the metabolic
fingerprint diagnosis model (AUCgt, 0.91) and the performance of the
metabolic marker panel (AUCgt, 0.92) are obviously superior to those of an existing'ultrasonic + beta-hCG 'diagnosis mode, the problems of diagnosis
delay, misdiagnosis and
missed diagnosis clinically at present are effectively solved, and the clinical rigid requirements of early and accurate diagnosis are met; the
fracture risk prediction model AUC 0.885 constructed by the method disclosed by the invention fills the current clinical blank. Key decision support can be provided for doctors, early intervention on high-risk patients is achieved, excessive
medical treatment on low-risk patients is avoided, and the mortality risk of pregnant and
lying-in women is reduced. According to the invention, based on the
nanoparticle-assisted
laser desorption /
ionization mass spectrometry technology, ultra-fast detection of only about 3 seconds for
single sample detection is realized, and the method is expected to become a fast detection tool in
emergency treatment and
outpatient service scenes.